• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 3DMAX; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 3DMAX; SURGICAL MESH Back to Search Results
Catalog Number 0115311
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Fever (1858); Unspecified Infection (1930); Weakness (2145)
Event Date 01/20/2021
Event Type  Injury  
Manufacturer Narrative
As reported, the patient experienced infection post implant of 3dmax mesh, underwent surgery intervention for mesh explant.Based on the information provided to date, no conclusion can be made as to the degree to which the device, may have caused or contributed the patient¿s reported postoperative course.Infection is a known inherent risk of surgery.The warnings section of the instructions-for-use supplied with the device states "if an infection develops, treat the infection aggressively.Consideration should be given regarding the need to remove the mesh.An unresolved infection may require removal of the device." a review of the manufacturing records was performed and found that the lot was manufactured to specification.To date, this is the only reported complaint from this manufacturing lot of 662 units released for distribution in june, 2019.This mdr represents the bard/davol 3dmax implanted on the patient¿s left side (device #1).An additional mdr was submitted to represent the bard/davol 3dmax implanted on the patient¿s right side (device #2).Should additional information be provided, a supplemental mdr will be submitted.
 
Event Description
It was reported that during a laparoscopic procedure on (b)(6) 2020, the patient underwent bilateral implant of two bard/davol 3dmax meshes.It was reported that on (b)(6) 2020, post-implant, patient started having fever, weakness and infection, which was confirmed with mri and sonography.As reported, on (b)(6) 2021, both mesh devices were explanted through a laparoscopic procedure.It was also reported that patient is currently on iv antibiotic piptaz (piperacillin tazobactum).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
3DMAX
Type of Device
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key11224379
MDR Text Key228625217
Report Number1213643-2021-20009
Device Sequence Number1
Product Code FTL
UDI-Device Identifier00801741030734
UDI-Public(01)00801741030734
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K081010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 01/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number0115311
Device Lot NumberHUDS2293
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/12/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/28/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age48 YR
-
-